Reaching Consensus on Defining, Treating High‑Risk Myeloma
The consensus was achieved at a July 2023 workshop, completed in early 2024, and awaits publication.
Evidence level: Állatkísérletes. Állatmodellben vizsgálták.
Related signals
- Multiple Myeloma Clinical Trials & Emerging Therapies
- S2209: Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM)
- Improved survival in multiple myeloma following prior detection of precursor conditions: a nationwide real-world study
- Nanomedicine-Empowered CAR‑T Therapy for Multiple Myeloma: Toward Programmable, Durable, and Precision Immunotherapy
- Toward a cure for multiple myeloma within a decade